Search results for: “biopharmaceutical”
-
Ipsen appoints Mari Scheiffele as EVP and President, Specialty Care International
•
PARIS, FRANCE: Ipsen announced the appointment of Mari Scheiffele as EVP and President, Specialty Care International, effective November…
-
AstraZeneca to fully acquire Caelum Biosciences
•
LONDON, UK: AstraZeneca‘s Alexion has exercised its option to acquire all remaining equity in Caelum Biosciences for CAEL-101,…
-
Inventia sells $30mn worth of American Depositary Shares
•
PARIS, FRANCE: Inventiva, a clinical-stage biopharmaceutical company, has completed sales of 2.083 million American Depositary Shares (ADS) pursuant…
-
Samsung unveils $206 billion expansion plan
•
SEOUL: Samsung Group will invest 240 trillion won ($206 billion) in the next three years to expand its…
-
HUTCHMED selected for certain Hang Seng Indexes
•
HONG KONG: HUTCHMED (China) Limited announced that HUTCHMED has been selected as a constituent stock of several indexes…
-
Advanced Instruments to buy Solentim for $240mn
•
STOCKHOLM, SWEDEN: Advanced Instruments has signed an agreement to acquire Solentim, a global leader in innovative solutions for…
-
EQT Private Equity and Goldman Sachs to acquire Parexel for $8.5 billion
•
BOSTON: Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies…
-
ViiV Healthcare and Halozyme enter global collaboration and license agreement for HIV medicine
•
LONDON, UK: Halozyme‘s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable…
-
Greg Madison appointed CEO of Shield Therapeutics
•
LONDON, UK: Shield Therapeutics plc (LON: STX) announced that Greg Madison has been appointed as Chief Executive Officer…
-
AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan
•
LONDON: AstraZeneca‘s COVID-19 vaccine, Vaxzevria, formerly AZD1222, has been granted a special approval for emergency use in Japan…
-
MaxCyte Inc plans public offering of shares on Nasdaq Stock Market
•
MARYLAND: MaxCyte Inc. (LON: MXCT) has confidentially submitted a draft registration statement on Form S-1 with the Securities…
-
Athenex Inc. acquires IP Group’s portfolio company Kuur Therapeutics for $185 million
•
LONDON: IP Group plc (LON: IPO) announced that its portfolio company Kuur Therapeutics Ltd has been acquired by…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.